Branche, A., Mulligan, M. J., Maniar, A., Puente, O., Oladipupo, I., Crowther, G., . . . Lindert, K. A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults. MDPI AG.
Chicago Style (17th ed.) CitationBranche, Angela, et al. A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults. MDPI AG.
MLA (9th ed.) CitationBranche, Angela, et al. A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults. MDPI AG.
Warning: These citations may not always be 100% accurate.